Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (32)

2024

  1. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. Real-world clinical outcomes with a next-generation left atrial appendage closure device: the FLXibility Post-Approval Study

    Europace, Vol. 25, Núm. 3, pp. 914-921

  2. Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 14, pp. 1197-1200

  3. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

    Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5

2022

  1. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  2. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure

    Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1098-1106

2021

  1. Comparison of Different Procedural Approaches for Left Atrial Appendage Closure: Searching for Simplicity

    Journal of Interventional Cardiology, Vol. 2021

  2. Outcomes of nonagenarians after transcatheter aortic valve implantation

    REC: Interventional Cardiology, Vol. 3, Núm. 4, pp. 250-257

  3. The de winter electrocardiographic pattern as an st-elevation myocardial infarction equivalent in a young patient with covid-19

    Emergencias

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  2. Embolisation of prostate arteries in benign prostatic hyperplasia in non-surgical patients

    Radiologia, Vol. 62, Núm. 3, pp. 205-212

  3. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  4. Major bleeding predictors in patients with left atrial appendage closure: The iberian registry ii

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-11

  5. Molecular inflammation and oxidative stress are shared mechanisms involved in both myocardial infarction and periodontitis

    Journal of Periodontal Research, Vol. 55, Núm. 4, pp. 519-528

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Left atrial appendage occlusion as adjunctive therapy to anticoagulation for stroke recurrence

    Journal of Invasive Cardiology, Vol. 31, Núm. 8, pp. 212-216

  3. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II

    Revista Espanola de Cardiologia, Vol. 72, Núm. 6, pp. 449-455

2018

  1. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients

    Molecular Therapy, Vol. 26, Núm. 11, pp. 2696-2709

2017

  1. A randomised trial of paclitaxel-eluting balloon after bare metal stent implantation vs. bare metal stent in ST-elevation myocardial infarction (the PEBSI study)

    EuroIntervention, Vol. 12, Núm. 13, pp. 1587-1594

  2. Could NLRP3-Inflammasome Be a Cardiovascular Risk Biomarker in Acute Myocardial Infarction Patients?

    Antioxidants and Redox Signaling, Vol. 27, Núm. 5, pp. 269-275